Graham Wardlow - Jun 10, 2024 Form 4 Insider Report for LUXFER HOLDINGS PLC (LXFR)

Role
Managing Director, Luxfer MEL Technologies
Signature
/s/ Megan E. Glise under Power of Attorney for Graham Wardlow
Stock symbol
LXFR
Transactions as of
Jun 10, 2024
Transactions value $
-$48,187
Form type
4
Date filed
6/12/2024, 12:48 PM
Previous filing
Mar 18, 2024
Next filing
Aug 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXFR Ordinary Shares Options Exercise +1.29K +4.19% 32K Jun 10, 2024 Direct F1
transaction LXFR Ordinary Shares Options Exercise +199 +0.62% 32.2K Jun 10, 2024 Direct F1
transaction LXFR Ordinary Shares Options Exercise +2.32K +7.19% 34.5K Jun 10, 2024 Direct F1
transaction LXFR Ordinary Shares Options Exercise +800 +2.32% 35.3K Jun 10, 2024 Direct F1
transaction LXFR Ordinary Shares Options Exercise +87 +0.25% 35.4K Jun 10, 2024 Direct F1
transaction LXFR Ordinary Shares Options Exercise +1.28K +3.62% 36.7K Jun 10, 2024 Direct F1
transaction LXFR Ordinary Shares Options Exercise +1K +2.73% 37.7K Jun 10, 2024 Direct F1
transaction LXFR Ordinary Shares Options Exercise +83 +0.22% 37.7K Jun 10, 2024 Direct F1
transaction LXFR Ordinary Shares Options Exercise +1.15K +3.05% 38.9K Jun 10, 2024 Direct F1
transaction LXFR Ordinary Shares Options Exercise +55 +0.14% 38.9K Jun 10, 2024 Direct F1
transaction LXFR Ordinary Shares Tax liability -$48.2K -4.17K -10.71% $11.55 34.8K Jun 10, 2024 Direct
holding LXFR Ordinary Shares 7.52K Jun 10, 2024 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXFR Stock Options (Right to Buy) Options Exercise -1.29K -100% 0 Jun 10, 2024 Ordinary Shares 1.29K Direct F1, F2
transaction LXFR Dividend Equivalent Rights Options Exercise -199 -100% 0 Jun 10, 2024 Ordinary Shares 199 Direct F3
transaction LXFR Stock Options (Right to Buy) Options Exercise -2.32K -100% 0 Jun 10, 2024 Ordinary Shares 2.32K Direct F1, F4
transaction LXFR Stock Options (Right to Buy) Options Exercise -800 -50% 800 Jun 10, 2024 Ordinary Shares 800 Direct F1, F5
transaction LXFR Dividend Equivalent Rights Options Exercise -87 -48.6% 92 Jun 10, 2024 Ordinary Shares 87 Direct F3
transaction LXFR Stock Options (Right to Buy) Options Exercise -1.28K -50% 1.28K Jun 10, 2024 Ordinary Shares 1.28K Direct F1, F6
transaction LXFR Stock Options (Right to Buy) Options Exercise -1K -33.33% 2K Jun 10, 2024 Ordinary Shares 1K Direct F1, F7
transaction LXFR Dividend Equivalent Rights Options Exercise -83 -24.63% 254 Jun 10, 2024 Ordinary Shares 83 Direct F3
transaction LXFR Stock Options (Right to Buy) Options Exercise -1.15K -25% 3.45K Jun 10, 2024 Ordinary Shares 1.15K Direct F1, F8
transaction LXFR Dividend Equivalent Rights Options Exercise -55 -24.23% 172 Jun 10, 2024 Ordinary Shares 55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
F2 Represents the exercise of time-based Stock Options awarded on March 13, 2020. The subject Stock Options fully vested and were exercisable as of March 13, 2024. The time-based Stock Options are fully vested and exercised.
F3 Represents dividend equivalent rights accrued on employee Stock Options, which become exercisable proportionately with the Stock Options to which they relate. Each dividend equivalent right is the economic equivalent of one Ordinary Share. The subject dividend equivalent rights convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
F4 Represents the exercise of performance-based Stock Options (at 50% target) awarded on March 13, 2020. One-half of the performance-based Stock Options vested and became exercisable on March 13, 2023 upon achievement of relative Total Shareholder Return (TSR) goals for the performance period ended December 31, 2022, and the remaining balance vested on March 13, 2024. The performance-based Stock Options are fully vested and exercised.
F5 Represents the exercise of time-based Stock Options awarded on March 15, 2021. The subject Stock Options vested and were exercisable as of March 15, 2024. The remaining Stock Options vest and become exercisable on March 15, 2025.
F6 Represents the exercise of performance-based Stock Options (at 200% target) awarded on March 15, 2021. One-third of the performance-based Stock Options vested and became exercisable on March 15, 2023 upon the achievement of an adjusted diluted EPS performance measure for the performance period ended December 31, 2021. A further one-third of the performance-based Stock Options vested on March 15, 2024, and the remaining balance will vest and become exercisable on March 15, 2025.
F7 Represents the exercise of time-based Stock Options awarded on March 14, 2022. The subject Stock Options vested and were exercisable as of March 14, 2024. The remaining Stock Options vest and become exercisable in two equal annual installments on March 14, 2025 and March 14, 2026.
F8 Represents the exercise of time-based Stock Options awarded on March 20, 2023. The subject Stock Options vested and were exercisable as of March 20, 2024. The remaining Stock Options vest in three equal annual installments beginning on March 20, 2025.

Remarks:

Managing Director, Luxfer MEL Technologies